Related Experiment Video
Updated: Jun 24, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
Aortic stiffness, kidney disease, and renal transplantation
Sola Aoun Bahous1, Jacques Blacher, Michel E Safar
1Diagnosis and Therapeutic Center, Hôpital Hôtel-Dieu, 1, Place du Parvis Notre-Dame, 75181 Paris Cedex 04, France.
Insights
High blood pressure in chronic kidney disease (CKD) patients accelerates kidney damage and cardiovascular risks. Managing systolic blood pressure is crucial for slowing disease progression and preventing major adverse events.
Area of Science:
- Nephrology
- Cardiology
- Vascular Biology
Background:
- High systolic blood pressure is a significant risk factor for chronic kidney disease (CKD) progression and cardiovascular (CV) events.
- Aortic stiffness and reduced kidney function are closely linked, even independent of traditional CV risk factors.
- Renal transplant recipients often exhibit increased aortic stiffness, influenced by donor age and acute rejection.
Purpose of the Study:
- To investigate the relationship between aortic stiffness, renal function, and cardiovascular risk in various kidney disease populations.
- To explore the impact of renal dysfunction on systemic pulse pressure and its transmission to the glomeruli.
- To assess the potential of pharmacologic modulation of the renin-angiotensin system in end-stage renal disease (ESRD).
Main Methods:
- Cross-sectional analysis of patients with mild to severe renal insufficiency.
- Evaluation of aortic stiffness in renal transplant patients.
- Observational study in subjects with end-stage renal disease and high CV risk.
Main Results:
- Increased aortic stiffness correlates with reduced creatinine clearance in CKD patients.
- Aortic stiffness is elevated in renal transplant patients, with donor age and rejection as contributing factors.
- Renal dysfunction can lead to increased systemic pulse pressure, potentially damaging glomeruli and increasing CV events.
Conclusions:
- Managing systolic blood pressure is vital for slowing CKD progression and reducing CV events.
- Aortic stiffness is a key factor linking kidney disease and cardiovascular complications.
- Targeting the renin-angiotensin system may offer a protective strategy for ESRD patients at high CV risk.
Abstract:
In subjects with chronic kidney disease (CKD), treatment of high systolic blood pressure is a key element in preventing disease progression and the occurrence of cardiovascular (CV) events. This relationship between the large arterial system and kidney function was demonstrated in different renal populations. In subjects with mild to severe renal insufficiency, increased aortic stiffness and reduced creatinine clearance are closely related and are independent of traditional CV risk factors. In renal transplant patients, aortic stiffness is significantly increased irrespective of donor type. Donor age and/or acute rejection contribute independently to the increased stiffness. In the presence of renal dysfunction, an increase in systemic pulse pressure frequently may be observed and transmitted to the glomeruli. This alteration potentially initiates renal damage and favors CV events. In subjects with end-stage renal disease and high CV risk, pharmacologic modulation of the renin-angiotensin system might prevent CKD progression and CV events.
Related Concept Videos
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Kidney Transplant I: Introduction
Aortic Regurgitation III: Medical Management
Hypertension II: Pathophysiology
Heart Failure Drugs: Diuretics
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

